These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 7889813)

  • 21. Methadone dose and heroin use during maintenance treatment.
    Caplehorn JR; Bell J; Kleinbaum DG; Gebski VJ
    Addiction; 1993 Jan; 88(1):119-24. PubMed ID: 8448501
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Contingency management in a methadone maintenance program: availability of reinforcers.
    Stitzer M; Bigelow G
    Int J Addict; 1978 Jul; 13(5):737-46. PubMed ID: 721332
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effects of lower-cost incentives on stimulant abstinence in methadone maintenance treatment: a National Drug Abuse Treatment Clinical Trials Network study.
    Peirce JM; Petry NM; Stitzer ML; Blaine J; Kellogg S; Satterfield F; Schwartz M; Krasnansky J; Pencer E; Silva-Vazquez L; Kirby KC; Royer-Malvestuto C; Roll JM; Cohen A; Copersino ML; Kolodner K; Li R
    Arch Gen Psychiatry; 2006 Feb; 63(2):201-8. PubMed ID: 16461864
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prohibition of take-home dosages: negative consequences on methadone maintenance treatment.
    Pani PP; Pirastu R; Ricci A; Gessa GL
    Drug Alcohol Depend; 1996 May; 41(1):81-4. PubMed ID: 8793314
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Psychoeducational group approach: HIV risk reduction in drug users.
    Sorensen JL; London J; Heitzmann C; Gibson DR; Morales ES; Dumontet R; Acree M
    AIDS Educ Prev; 1994 Apr; 6(2):95-112. PubMed ID: 8018443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Assessing the helping alliance and its impact in the treatment of opiate dependence.
    Belding MA; Iguchi MY; Morral AR; McLellan AT
    Drug Alcohol Depend; 1997 Oct; 48(1):51-9. PubMed ID: 9330921
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Improvement in naltrexone treatment compliance with contingency management.
    Preston KL; Silverman K; Umbricht A; DeJesus A; Montoya ID; Schuster CR
    Drug Alcohol Depend; 1999 Apr; 54(2):127-35. PubMed ID: 10217552
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The risks of diverted take-home methadone.
    McGloughlin S; Castle E; Coulter C; Fraser JF
    Aust N Z J Public Health; 2010 Feb; 34(1):93-4. PubMed ID: 20920116
    [No Abstract]   [Full Text] [Related]  

  • 29. Evaluating the reinforcement value of clinic-based privileges through a multiple choice procedure.
    Kidorf M; Stitzer ML; Griffiths RR
    Drug Alcohol Depend; 1995 Oct; 39(3):167-72. PubMed ID: 8556964
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Client variables associated with selection and outcome in a methadone tapering program.
    Capone CT; Haggerty EL; Acer K; Melchionda R; Holley E; Adams H; Logan F
    Int J Addict; 1994 Feb; 29(3):387-94. PubMed ID: 8188434
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Methadone doses of 100 mg or greater are more effective than lower doses at suppressing heroin self-administration in opioid-dependent volunteers.
    Donny EC; Brasser SM; Bigelow GE; Stitzer ML; Walsh SL
    Addiction; 2005 Oct; 100(10):1496-509. PubMed ID: 16185211
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Agonist-like or antagonist-like treatment for cocaine dependence with methadone for heroin dependence: two double-blind randomized clinical trials.
    Grabowski J; Rhoades H; Stotts A; Cowan K; Kopecky C; Dougherty A; Moeller FG; Hassan S; Schmitz J
    Neuropsychopharmacology; 2004 May; 29(5):969-81. PubMed ID: 15039761
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Medication take-home as a reinforcer in a methadone maintenance program.
    Stitzer M; Bigelow G; Lawrence C; Cohen J; D'Lugoff B; Hawthorne J
    Addict Behav; 1977; 2(1):9-14. PubMed ID: 848377
    [No Abstract]   [Full Text] [Related]  

  • 34. Comparing adaptive stepped care and monetary-based voucher interventions for opioid dependence.
    Brooner RK; Kidorf MS; King VL; Stoller KB; Neufeld KJ; Kolodner K
    Drug Alcohol Depend; 2007 May; 88 Suppl 2(Suppl 2):S14-23. PubMed ID: 17257782
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Contingency management in methadone maintenance: effects of reinforcing and aversive consequences on illicit polydrug use.
    Iguchi MY; Stitzer ML; Bigelow GE; Liebson IA
    Drug Alcohol Depend; 1988 Oct; 22(1-2):1-7. PubMed ID: 2906863
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A 12-month controlled trial of methadone medical maintenance integrated into an adaptive treatment model.
    King VL; Kidorf MS; Stoller KB; Schwartz R; Kolodner K; Brooner RK
    J Subst Abuse Treat; 2006 Dec; 31(4):385-93. PubMed ID: 17084792
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Client engagement and change during drug abuse treatment.
    Simpson DD; Joe GW; Rowan-Szal G; Greener J
    J Subst Abuse; 1995; 7(1):117-34. PubMed ID: 7655308
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of reinforcement probability and prize size on cocaine and heroin abstinence in prize-based contingency management.
    Ghitza UE; Epstein DH; Schmittner J; Vahabzadeh M; Lin JL; Preston KL
    J Appl Behav Anal; 2008; 41(4):539-49. PubMed ID: 19192858
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Monitoring in methadone maintenance treatment.
    Baker JG; Rounds JB; Carson CA
    Int J Addict; 1995 Jul; 30(9):1177-85. PubMed ID: 7591356
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A menu of potential reinforcers in a methadone maintenance program.
    Schmitz JM; Rhoades H; Grabowski J
    J Subst Abuse Treat; 1994; 11(5):425-31. PubMed ID: 7869463
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.